Annual Cash & Cash Equivalents
$34.61 M
-$1.85 M-5.07%
December 31, 2022
Summary
- As of February 10, 2025, DBTX annual cash & cash equivalents is $34.61 million, with the most recent change of -$1.85 million (-5.07%) on December 31, 2022.
- During the last 3 years, DBTX annual cash & cash equivalents has risen by +$16.01 million (+86.06%).
Performance
DBTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$39.80 M
+$1.74 M+4.57%
June 30, 2023
Summary
- As of February 10, 2025, DBTX quarterly cash and cash equivalents is $39.80 million, with the most recent change of +$1.74 million (+4.57%) on June 30, 2023.
- Over the past year, DBTX quarterly cash and cash equivalents has dropped by -$16.65 million (-29.49%).
Performance
DBTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DBTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.1% | -29.5% |
| 3 y3 years | +86.1% | - |
| 5 y5 years | +205.7% | - |
DBTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.1% | at low | -29.5% | -72.9% |
| 5 y | 5-year | -5.1% | -46.3% | -29.5% | -86.9% |
| alltime | all time | -5.1% | -67.3% | -29.5% | -86.9% |
Decibel Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $39.80 M(+4.6%) |
| Mar 2023 | - | $38.06 M(+10.0%) |
| Dec 2022 | $34.61 M(-5.1%) | $34.61 M(-5.7%) |
| Sep 2022 | - | $36.68 M(-35.0%) |
| Jun 2022 | - | $56.45 M(+423.7%) |
| Mar 2022 | - | $10.78 M(-70.4%) |
| Dec 2021 | $36.45 M | $36.45 M(-29.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $51.41 M(+36.4%) |
| Jun 2021 | - | $37.69 M(-27.9%) |
| Mar 2021 | - | $52.24 M(+88.3%) |
| Dec 2020 | $27.74 M(+49.2%) | $27.74 M(+433.7%) |
| Sep 2020 | - | $5.20 M(-72.1%) |
| Dec 2019 | $18.60 M(+64.3%) | $18.60 M |
| Dec 2018 | $11.32 M | - |
FAQ
- What is Decibel Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Decibel Therapeutics?
- What is Decibel Therapeutics annual cash & cash equivalents year-on-year change?
- What is Decibel Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Decibel Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DBTX is $34.61 M
What is the all time high annual cash & cash equivalents for Decibel Therapeutics?
Decibel Therapeutics all-time high annual cash & cash equivalents is $36.45 M
What is Decibel Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DBTX annual cash & cash equivalents has changed by -$1.85 M (-5.07%)
What is Decibel Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DBTX is $39.80 M
What is the all time high quarterly cash and cash equivalents for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly cash and cash equivalents is $56.45 M
What is Decibel Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DBTX quarterly cash and cash equivalents has changed by -$16.65 M (-29.49%)